21
Views
0
CrossRef citations to date
0
Altmetric
Articles

A Stability Indicating UHPLC Method for the Simultaneous Estimation of Perindopril, Indapamide in Presence of Potential Impurities: An Application of QbD for Robustness Study

, &
Pages 477-497 | Received 12 Jun 2020, Accepted 27 Aug 2020, Published online: 01 Nov 2020

References

  • Drugbank.com, Perindopril https://www.drugbank.ca/drugs/DB00790. Accessed, June-4, (2020).
  • Drugbank.com, Indapamide https://www.drugbank.ca/drugs/DB00808. Accessed, June-4, (2020).
  • https://www.geneesmiddeleninformatiebank.nl/Pars/h33663.pdf. Accessed, June-4, (2020).
  • https://www.servier.com.ve/sites/default/files/spc-pil/spc-preterax%2010mg.pdf. Accessed, June-4, (2020).
  • European Pharmacopoeia. (2019). 10th edition. European Directorate for the Quality of Medicines, Council of Europe, Strasbourg.
  • United States Pharmacopeia and National Formulary (USP 42-NF 37). (2019). Rockville, United States Pharmacopeia Convention.
  • Al-Tannak, N.F. (2018). UHPLC-UV method for simultaneous determination of perindopril arginine and indapamide hemihydrate in combined dosage form: a stability-indicating assay method. Scientia Pharmaceutica. 86: 7. doi: 10.3390/scipharm86010007
  • El-Bagary, R.I., Elkady, E.F., Mowaka, S., Attallah, M.A. (2017). A validated HPLC method for simultaneous determination of Perindopril Arginine, Amlodipine, and Indapamide: Application in bulk and in different pharmaceutical dosage forms. Journal of AOAC International.100: 992-999. doi: 10.5740/jaoacint.16-0279
  • Jogia, H., Khandelwal, U., Gandhi, T., Singh, S., Modi, D. (2010). Development and validation of a stability-indicating assay method for simultaneous determination of Perindopril and Indapamide in combined dosage form by reversed-phase High-Performance Liquid Chromatography. Journal of AOAC International. 93: 108-115. doi: 10.1093/jaoac/93.1.108
  • Amara Babu, N.L.A., Srinivas. B., Sreeram. V., Prabhakara, R.K. (2020). Development and validation for simultaneous estimation of Perindopril and Indapamide by UPLC-UV in tablet dosage form. Research Journal of Pharmacy and Technology. 13(1): 287-292. doi: 10.5958/0974-360X.2020.00058.X
  • Sai kiran, B.S., Babu, G.R., Kumari, M.V., Kumar, G.V. (2015). Stability indicating isocratic RP-HPLC method development and validation for Indapamide and Perindopril Erbumine in pure and its combined tablet dosage form. Int J Pharm Sci Res. 6(8): 3428-3438.
  • El Kawy, M.A., Younes, K.M., Shaimaa, M.A. (2012). Development and validation of HPLC method for the simultaneous determination of Perindopril and Indapamide in pharmaceutical formulations. Analytical chemistry an indian journal. 11(11, 12): 353-358.
  • Valentin, I., Silvia, I., Gabriela, C.A., Lucia, M.D. (2015). Analytical Performance of an HPLC and CZE Methods for the Analysis and Separation of Perindopril Erbumine and Indapamide. Acta Medica Marisiensis. 61(4):324-327. doi: 10.1515/amma-2015-0073
  • ICH Harmonized Tripartite Guideline (2003). Stability Testing of New Drug Substances and Products Q1A (R2).
  • Bakshi, M., Singh, S. (2002). Development of validated stability-indicating assay methods-critical review. Journal of Pharmaceutical and Biomedical Analysis. 28: 1011-1040. doi: 10.1016/S0731-7085(02)00047-X
  • ICH Harmonized Tripartite Guideline (2009). Pharmaceutical Development Q8 (R2).
  • Karmarkar, S., Garber, R., Genchanok, Y., George, S., Yang, X., Hammond, R. (2011). Quality by Design (QbD) Based Development of a Stability Indicating HPLC Method for Drug and Impurities. J. Chrom. Sci. 49: 439–446 doi: 10.1093/chrsci/49.6.439
  • ICH Harmonized Tripartite Guideline (2005). Validation of analytical procedures: text and methodology Q2 (R1).
  • ICH Harmonized Tripartite Guideline (1996). Stability Testing: Photostability testing of New Drug Substances and Products.
  • Snyder, L.R., Kirkland, J.J., Dolan. J.W. (2010). Introduction to modern liquid chromatography, 3rd ed. John wiley & sons, New Jersey. 439 p.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.